Abstract

Hyperalgesia often occurs in alcoholics, especially during abstinence, yet the underlying mechanisms remain elusive. The lateral habenula (LHb) has been implicated in the pathophysiology of pain and alcohol use disorders. Suppression of m-type potassium channels (M-channels) has been found to contribute to the hyperactivity of LHb neurons of rats withdrawn from chronic alcohol administration. Here, we provided evidence that LHb M-channels may contribute to hyperalgesia. Compared to alcohol naïve counterparts, in male Long-Evans rats at 24-hours withdrawal from alcohol administration under the intermittent access paradigm for eight weeks, hyperalgesia was evident (as measured by paw withdrawal latencies in the Hargreaves Test), which was accompanied with higher basal activities of LHb neurons in brain slices, and lower M-channel protein expression. Inhibition of LHb neurons by chemogenetics, or pharmacological activation of M-channels, as well as overexpression of M-channels’ subunit KCNQ3, relieved hyperalgesia and decreased relapse-like alcohol consumption. In contrast, chemogenetic activation of LHb neurons induced hyperalgesia in alcohol-naive rats. These data reveal a central role for the LHb in hyperalgesia during alcohol withdrawal, which may be due in part to the suppression of M-channels and, thus, highlights M-channels in the LHb as a potential therapeutic target for hyperalgesia in alcoholics.

Details

Title
Downregulation of M-channels in lateral habenula mediates hyperalgesia during alcohol withdrawal in rats
Author
Kang Seungwoo 1   VIAFID ORCID Logo  ; Li, Jing 2 ; Zuo Wanhong 2 ; Chen, Pei 2 ; Gregor, Danielle 2 ; Rao, Fu 2 ; Han, Xiao 2 ; Bekker, Alex 2 ; Jiang-Hong, Ye 2 

 The State University of New Jersey, New Jersey Medical School, Department of Anesthesiology, Rutgers, Newark, USA (GRID:grid.469131.8) (ISNI:0000 0000 8692 8176); The State University of New Jersey, New Jersey Medical School, Pharmacology, Physiology, and Neuroscience, Rutgers, Newark, USA (GRID:grid.469131.8) (ISNI:0000 0000 8692 8176); Mayo Clinic College of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X) 
 The State University of New Jersey, New Jersey Medical School, Department of Anesthesiology, Rutgers, Newark, USA (GRID:grid.469131.8) (ISNI:0000 0000 8692 8176); The State University of New Jersey, New Jersey Medical School, Pharmacology, Physiology, and Neuroscience, Rutgers, Newark, USA (GRID:grid.469131.8) (ISNI:0000 0000 8692 8176) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2185861449
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.